Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
NCT06410131
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
FTL008.16
Sponsor
Sound Biopharmaceuticals Ltd.